Skip to main content
Erschienen in: Journal of Neurology 12/2020

27.06.2020 | Original Communication

Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies

verfasst von: Giovanni Palermo, Eleonora Del Prete, Ubaldo Bonuccelli, Roberto Ceravolo

Erschienen in: Journal of Neurology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Differential diagnosis between Parkinson's disease, dementia with Lewy bodies and multiple system atrophy can be difficult, especially because in early phase they might present with overlapping clinical features. Notably, orthostatic hypotension and cognitive dysfunction are common nonmotor aspects of parkinsonian syndromes and can be both present from the earliest stages of all α-synucleinopathies, indicating a common neurobiological basis in their strong relationship. In view of the increasing awareness about the prevalence of mild cognitive dysfunction in multiple system atrophy, the relevance of autonomic dysfunction in demented parkinsonian patients, the critical role of non-motor symptoms in clustering Parkinson's disease patients and the shift to studying patients in the prodromal phase, we will discuss some intrinsic limitations of current clinical diagnostic criteria, even when applied by movement disorder specialists. In particular, we will focus on the early coexistence of autonomic and cognitive dysfunction in the setting of overt or latent parkinsonism as pitfalls in the differential diagnosis of α-synucleinopathies. As early and accurate diagnosis remains of outmost importance for counselling of patients and timely enrolment into disease-modifying clinical trials, a continuous effort of research community is ongoing to further improve the clinical diagnostic accuracy of α-synucleinopathies.
Literatur
1.
Zurück zum Zitat Spillantini MG, Goedert M (2000) The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16–27PubMed Spillantini MG, Goedert M (2000) The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16–27PubMed
2.
Zurück zum Zitat Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, Miller BL (2009) Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. Alzheimer Dis Assoc Disord 23(4):365–370PubMedPubMedCentral Kao AW, Racine CA, Quitania LC, Kramer JH, Christine CW, Miller BL (2009) Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy. Alzheimer Dis Assoc Disord 23(4):365–370PubMedPubMedCentral
3.
Zurück zum Zitat Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125(4):861–870PubMed Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002) The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125(4):861–870PubMed
4.
Zurück zum Zitat Mendoza-Velásquez JJ, Flores-Vázquez JF, Barrón-Velázquez E, Sosa-Ortiz AL, Illigens BW, Siepmann T (2019) Autonomic dysfunction in α-synucleinopathies. Front Neurol 10:363PubMedPubMedCentral Mendoza-Velásquez JJ, Flores-Vázquez JF, Barrón-Velázquez E, Sosa-Ortiz AL, Illigens BW, Siepmann T (2019) Autonomic dysfunction in α-synucleinopathies. Front Neurol 10:363PubMedPubMedCentral
5.
Zurück zum Zitat Colosimo C, Morgante L, Antonini A et al (2010) Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 257(1):5–14PubMed Colosimo C, Morgante L, Antonini A et al (2010) Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 257(1):5–14PubMed
6.
Zurück zum Zitat Ha AD, Brown CH, York MK, Jankovic J (2011) The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord 17(8):625–628PubMed Ha AD, Brown CH, York MK, Jankovic J (2011) The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord 17(8):625–628PubMed
7.
Zurück zum Zitat Idiaquez J, Roman GC (2011) Autonomic dysfunction in neurodegenerative dementias. J Neurol Sci 305(1–2):22–27PubMed Idiaquez J, Roman GC (2011) Autonomic dysfunction in neurodegenerative dementias. J Neurol Sci 305(1–2):22–27PubMed
8.
Zurück zum Zitat Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, Barker RA (2013) The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84(11):1258–1264PubMed Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, Barker RA (2013) The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84(11):1258–1264PubMed
9.
Zurück zum Zitat McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88–100PubMedPubMedCentral McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88–100PubMedPubMedCentral
10.
Zurück zum Zitat Stankovic I, Quinn N, Vignatelli L et al (2019) A critique of the second consensus criteria for multiple system atrophy. Mov Disord 34(7):975–984PubMedPubMedCentral Stankovic I, Quinn N, Vignatelli L et al (2019) A critique of the second consensus criteria for multiple system atrophy. Mov Disord 34(7):975–984PubMedPubMedCentral
11.
Zurück zum Zitat Bonuccelli U, Lucetti C, Del Dotto P, Ceravolo R, Gambaccini G, Bernardini S, Rossi G, Piaggesi A (2003) Orthostatic hypotension in de novo Parkinson’s disease. Arch Neurol 60:1400–1404PubMed Bonuccelli U, Lucetti C, Del Dotto P, Ceravolo R, Gambaccini G, Bernardini S, Rossi G, Piaggesi A (2003) Orthostatic hypotension in de novo Parkinson’s disease. Arch Neurol 60:1400–1404PubMed
12.
Zurück zum Zitat Kaufmann H, Nahm K, Purohit D, Wolfe D (2004) Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63(6):1093–1095PubMed Kaufmann H, Nahm K, Purohit D, Wolfe D (2004) Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63(6):1093–1095PubMed
13.
Zurück zum Zitat Kandiah N, Narasimhalu K, Lau PN, Seah SH, Au WL, Tan LC (2009) Cognitive decline in early Parkinson's disease. Mov Disord 24(4):605–608PubMed Kandiah N, Narasimhalu K, Lau PN, Seah SH, Au WL, Tan LC (2009) Cognitive decline in early Parkinson's disease. Mov Disord 24(4):605–608PubMed
14.
Zurück zum Zitat Fiorenzato E, Antonini A, Wenning G, Biundo R (2017) Cognitive impairment in multiple system atrophy. Mov Disord 32(9):1338–1339PubMed Fiorenzato E, Antonini A, Wenning G, Biundo R (2017) Cognitive impairment in multiple system atrophy. Mov Disord 32(9):1338–1339PubMed
15.
Zurück zum Zitat Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, Ziemssen T (2012) Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 27(5):617–626PubMed Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, Ziemssen T (2012) Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 27(5):617–626PubMed
16.
Zurück zum Zitat Jecmenica-Lukic M, Poewe W, Tolosa E, Wenning GK (2012) Premotor signs and symptoms of multiple system atrophy. Lancet Neurol 11(4):361–368PubMed Jecmenica-Lukic M, Poewe W, Tolosa E, Wenning GK (2012) Premotor signs and symptoms of multiple system atrophy. Lancet Neurol 11(4):361–368PubMed
17.
Zurück zum Zitat Donaghy PC, O'Brien JT, Thomas AJ (2015) Prodromal dementia with Lewy bodies. Psychol Med 45(2):259–268PubMed Donaghy PC, O'Brien JT, Thomas AJ (2015) Prodromal dementia with Lewy bodies. Psychol Med 45(2):259–268PubMed
18.
Zurück zum Zitat Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 30(12):1591–1601PubMed Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 30(12):1591–1601PubMed
19.
Zurück zum Zitat Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752PubMedPubMedCentral Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752PubMedPubMedCentral
20.
Zurück zum Zitat Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32:S125–S127PubMed Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson’s disease. Ann Neurol 32:S125–S127PubMed
21.
Zurück zum Zitat Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33–39PubMed Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33–39PubMed
22.
Zurück zum Zitat Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676PubMedPubMedCentral Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676PubMedPubMedCentral
23.
Zurück zum Zitat Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA (2007) Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry 78(7):671–677PubMed Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA (2007) Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry 78(7):671–677PubMed
24.
Zurück zum Zitat Rajput AH, Rozdilsky B, Rajput A (1991) Accuracy of clinical diagnosis in parkinsonism—a prospective study. Can J Neurol Sci 18:275–278PubMed Rajput AH, Rozdilsky B, Rajput A (1991) Accuracy of clinical diagnosis in parkinsonism—a prospective study. Can J Neurol Sci 18:275–278PubMed
25.
Zurück zum Zitat Jankovic J, Rajput AH, McDermott MP, Perl DP (2000) The evolution of diagnosis in early Parkinson disease. Parkinson Study Group Arch Neurol 57:369–372 Jankovic J, Rajput AH, McDermott MP, Perl DP (2000) The evolution of diagnosis in early Parkinson disease. Parkinson Study Group Arch Neurol 57:369–372
26.
Zurück zum Zitat Adler CH, Beach TG, Hentz JG et al (2014) Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology 83:406–412PubMedPubMedCentral Adler CH, Beach TG, Hentz JG et al (2014) Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology 83:406–412PubMedPubMedCentral
27.
Zurück zum Zitat Beach TG, Adler CH (2018) Importance of low diagnostic accuracy for early Parkinson's disease. Mov Disord 33(10):1551–1554PubMedPubMedCentral Beach TG, Adler CH (2018) Importance of low diagnostic accuracy for early Parkinson's disease. Mov Disord 33(10):1551–1554PubMedPubMedCentral
28.
Zurück zum Zitat Postuma RB, Poewe W, Litvan I et al (2018) Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 33(10):1601–1608PubMed Postuma RB, Poewe W, Litvan I et al (2018) Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 33(10):1601–1608PubMed
29.
Zurück zum Zitat Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86(6):566–576PubMed Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (2016) Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86(6):566–576PubMed
30.
Zurück zum Zitat Kalia LV, Lang AE (2015) Parkinson's disease. Lancet 386(9996):896–912PubMed Kalia LV, Lang AE (2015) Parkinson's disease. Lancet 386(9996):896–912PubMed
31.
Zurück zum Zitat Marras C, Lang A (2013) Parkinson's disease subtypes: lost in translation? J Neurol Neurosurg Psychiatry 84(4):409–415PubMed Marras C, Lang A (2013) Parkinson's disease subtypes: lost in translation? J Neurol Neurosurg Psychiatry 84(4):409–415PubMed
32.
Zurück zum Zitat Zis P, Martinez-Martin P, Sauerbier A, Rizos A, Sharma JC, Worth PF, Sophia R, Silverdale M, Chaudhuri KR (2015) Non-motor symptoms burden in treated and untreated early Parkinson’s disease patients: argument for non-motor subtypes. Eur J Neurol 22:1145–1150PubMed Zis P, Martinez-Martin P, Sauerbier A, Rizos A, Sharma JC, Worth PF, Sophia R, Silverdale M, Chaudhuri KR (2015) Non-motor symptoms burden in treated and untreated early Parkinson’s disease patients: argument for non-motor subtypes. Eur J Neurol 22:1145–1150PubMed
33.
Zurück zum Zitat Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB (2015) New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72:863–867PubMed Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB (2015) New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol 72:863–867PubMed
34.
Zurück zum Zitat Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression. Brain 140(7):1959–1976PubMed Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression. Brain 140(7):1959–1976PubMed
35.
Zurück zum Zitat Pilotto A, Romagnolo A, Tuazon JA et al (2019) Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies. J Neurol Neurosurg Psychiatry 90(11):1257–1263PubMed Pilotto A, Romagnolo A, Tuazon JA et al (2019) Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies. J Neurol Neurosurg Psychiatry 90(11):1257–1263PubMed
36.
Zurück zum Zitat Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW (2015) When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 85(5):404–412PubMedPubMedCentral Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, Wszolek ZK, Langston JW, Dickson DW (2015) When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology 85(5):404–412PubMedPubMedCentral
37.
Zurück zum Zitat Miki Y, Foti SC, Asi YT, Tsushima E, Quinn N, Ling H, Holton JL (2019) Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain 142(9):2813–2827PubMed Miki Y, Foti SC, Asi YT, Tsushima E, Quinn N, Ling H, Holton JL (2019) Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. Brain 142(9):2813–2827PubMed
38.
Zurück zum Zitat Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89(4):358–366PubMed Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G (2018) Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 89(4):358–366PubMed
39.
Zurück zum Zitat Fanciulli A, Goebel G, Lazzeri G et al (2019) Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease. Mov Disord 34(3):440–441PubMed Fanciulli A, Goebel G, Lazzeri G et al (2019) Early distinction of Parkinson-variant multiple system atrophy from Parkinson's disease. Mov Disord 34(3):440–441PubMed
40.
Zurück zum Zitat Kim HJ, Stamelou M, Jeon B (2016) Multiple system atrophy-mimicking conditions: Diagnostic challenges. Parkinsonism Relat Disord 22(Suppl 1):S12–S15PubMed Kim HJ, Stamelou M, Jeon B (2016) Multiple system atrophy-mimicking conditions: Diagnostic challenges. Parkinsonism Relat Disord 22(Suppl 1):S12–S15PubMed
41.
Zurück zum Zitat Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372(3):249–263PubMed Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N Engl J Med 372(3):249–263PubMed
42.
Zurück zum Zitat Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP (2000) What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 68(4):434–440PubMedPubMedCentral Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP (2000) What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry 68(4):434–440PubMedPubMedCentral
43.
Zurück zum Zitat Riley DE, Chelimsky TC (2003) Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease. J Neurol Neurosurg Psychiatry 74(1):56–60PubMedPubMedCentral Riley DE, Chelimsky TC (2003) Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease. J Neurol Neurosurg Psychiatry 74(1):56–60PubMedPubMedCentral
44.
Zurück zum Zitat Kimpinski K, Iodice V, Burton DD et al (2012) The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy. J Neurol Sci 317(1–2):92–96PubMedPubMedCentral Kimpinski K, Iodice V, Burton DD et al (2012) The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy. J Neurol Sci 317(1–2):92–96PubMedPubMedCentral
45.
Zurück zum Zitat Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33(3):349–358PubMed Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33(3):349–358PubMed
46.
Zurück zum Zitat Merola A, Espay AJ, Zibetti M, Romagnolo A, Rosso M, Maule S, Lopiano L (2017) Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside. Mov Disord Clin Pract 4(1):141–144PubMed Merola A, Espay AJ, Zibetti M, Romagnolo A, Rosso M, Maule S, Lopiano L (2017) Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside. Mov Disord Clin Pract 4(1):141–144PubMed
47.
Zurück zum Zitat Nagayama H, Ueda M, Yamazaki M, Nishiyama Y, Hamamoto M, Katayama Y (2010) Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy. Mov Disord 25(11):1744–1747PubMed Nagayama H, Ueda M, Yamazaki M, Nishiyama Y, Hamamoto M, Katayama Y (2010) Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy. Mov Disord 25(11):1744–1747PubMed
48.
Zurück zum Zitat Ikeda T, Ikenoshita S, Sakamoto F, Shiraishi S, Nakahara K, Masuda T, Yamashita S (2019) Is 123I-MIBG scintigraphy beneficial or excessive for the diagnosis of Parkinson's disease in the early phase? Neurodegener Dis 19(2):88–95PubMed Ikeda T, Ikenoshita S, Sakamoto F, Shiraishi S, Nakahara K, Masuda T, Yamashita S (2019) Is 123I-MIBG scintigraphy beneficial or excessive for the diagnosis of Parkinson's disease in the early phase? Neurodegener Dis 19(2):88–95PubMed
49.
Zurück zum Zitat Lippa CF, Duda JE, Grossman M et al (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68:812–819PubMed Lippa CF, Duda JE, Grossman M et al (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68:812–819PubMed
50.
Zurück zum Zitat Goldstein DS (2006) Orthostatic hypotension as an early finding in Parkinson's disease. Clin Auton Res 16(1):46–54PubMed Goldstein DS (2006) Orthostatic hypotension as an early finding in Parkinson's disease. Clin Auton Res 16(1):46–54PubMed
51.
Zurück zum Zitat Hiorth YH, Pedersen KF, Dalen I, Tysnes OB, Alves G (2019) Orthostatic hypotension in Parkinson disease: a 7-year prospective population-based study. Neurology 93(16):e1526–e1534PubMed Hiorth YH, Pedersen KF, Dalen I, Tysnes OB, Alves G (2019) Orthostatic hypotension in Parkinson disease: a 7-year prospective population-based study. Neurology 93(16):e1526–e1534PubMed
52.
Zurück zum Zitat Saito F, Tsuchiya K, Kotera M (1992) An autopsied case of Parkinson’s disease manifesting Shy-Drager syndrome. Rinsho Shinkeigaku 32(11):1238–1244PubMed Saito F, Tsuchiya K, Kotera M (1992) An autopsied case of Parkinson’s disease manifesting Shy-Drager syndrome. Rinsho Shinkeigaku 32(11):1238–1244PubMed
53.
Zurück zum Zitat Benarroch EE, Schmeichel AM, Parisi JE (2000) Involvement of the ventrolateral medulla in parkinsonism with autonomic failure. Neurology 54:963–968PubMed Benarroch EE, Schmeichel AM, Parisi JE (2000) Involvement of the ventrolateral medulla in parkinsonism with autonomic failure. Neurology 54:963–968PubMed
54.
Zurück zum Zitat Magalhaes M, Wenning GK, Daniel SE, Quinn NP (1995) Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson’s disease – a retrospective comparison. Acta Neurol Scand 91:98–102PubMed Magalhaes M, Wenning GK, Daniel SE, Quinn NP (1995) Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson’s disease – a retrospective comparison. Acta Neurol Scand 91:98–102PubMed
55.
Zurück zum Zitat Kim HJ, Jeon B, Fung VSC (2016) Role of magnetic resonance imaging in the diagnosis of multiple system atrophy. Mov Disord Clin Pract 4(1):12–20PubMedPubMedCentral Kim HJ, Jeon B, Fung VSC (2016) Role of magnetic resonance imaging in the diagnosis of multiple system atrophy. Mov Disord Clin Pract 4(1):12–20PubMedPubMedCentral
56.
Zurück zum Zitat Fanciulli A, Stankovic I, Krismer F, Seppi K, Levin J, Wenning GK (2019) Multiple system atrophy. Int Rev Neurobiol 149:137–192PubMed Fanciulli A, Stankovic I, Krismer F, Seppi K, Levin J, Wenning GK (2019) Multiple system atrophy. Int Rev Neurobiol 149:137–192PubMed
57.
Zurück zum Zitat Xu Z, Arbizu J, Pavese N (2018) PET molecular imaging in atypical parkinsonism. Int Rev Neurobiol 142:3–36PubMed Xu Z, Arbizu J, Pavese N (2018) PET molecular imaging in atypical parkinsonism. Int Rev Neurobiol 142:3–36PubMed
58.
Zurück zum Zitat Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I et al (2019) Transcranial sonography in atypical parkinsonism: how reliable is it in real clinical practice? A multicentre comprehensive study. Parkinsonism Relat Disord 68:40–45PubMed Alonso-Canovas A, Tembl Ferrairó JI, Martínez-Torres I et al (2019) Transcranial sonography in atypical parkinsonism: how reliable is it in real clinical practice? A multicentre comprehensive study. Parkinsonism Relat Disord 68:40–45PubMed
59.
Zurück zum Zitat Kaufmann H, Norcliffe-Kaufmann L, Palma JA et al (2017) Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol 81(2):287–297PubMedPubMedCentral Kaufmann H, Norcliffe-Kaufmann L, Palma JA et al (2017) Natural history of pure autonomic failure: a United States prospective cohort. Ann Neurol 81(2):287–297PubMedPubMedCentral
60.
Zurück zum Zitat Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211PubMed Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211PubMed
61.
Zurück zum Zitat Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396(1):67–72PubMed Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396(1):67–72PubMed
62.
Zurück zum Zitat Goldstein DS, Holmes C, Sharabi Y, Wu T (2015) Survival in synucleinopathies: a prospective cohort study. Neurology 85(18):1554–1561PubMedPubMedCentral Goldstein DS, Holmes C, Sharabi Y, Wu T (2015) Survival in synucleinopathies: a prospective cohort study. Neurology 85(18):1554–1561PubMedPubMedCentral
63.
Zurück zum Zitat De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT (2017) Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA Neurol 74(8):970–976PubMedPubMedCentral De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT (2017) Association of autonomic dysfunction with disease progression and survival in Parkinson disease. JAMA Neurol 74(8):970–976PubMedPubMedCentral
64.
Zurück zum Zitat Anang JBM, Gagnon JF, Bertrand JA, Romenets SR, Latreille V, Panisset M, Montplaisir J, Postuma RB (2014) Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology 83:1253–1260PubMedPubMedCentral Anang JBM, Gagnon JF, Bertrand JA, Romenets SR, Latreille V, Panisset M, Montplaisir J, Postuma RB (2014) Predictors of dementia in Parkinson disease: a prospective cohort study. Neurology 83:1253–1260PubMedPubMedCentral
65.
Zurück zum Zitat Thaisetthawatkul P, Boeve BF, Benarroch EE, Sandroni P, Ferman TJ, Petersen R, Low PA (2004) Autonomic dysfunction in dementia with Lewy bodies. Neurology 62:1804–1809PubMed Thaisetthawatkul P, Boeve BF, Benarroch EE, Sandroni P, Ferman TJ, Petersen R, Low PA (2004) Autonomic dysfunction in dementia with Lewy bodies. Neurology 62:1804–1809PubMed
66.
Zurück zum Zitat Stubendorff K, Aarsland D, Minthon L, Londos E (2012) The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia. PLoS ONE 7(10):e45451PubMedPubMedCentral Stubendorff K, Aarsland D, Minthon L, Londos E (2012) The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia. PLoS ONE 7(10):e45451PubMedPubMedCentral
67.
Zurück zum Zitat Pakiam AS, Bergeron C, Lang AE (1999) Diffuse Lewy body disease presenting as multiple system atrophy. Can J Neurol Sci 26:127–131PubMed Pakiam AS, Bergeron C, Lang AE (1999) Diffuse Lewy body disease presenting as multiple system atrophy. Can J Neurol Sci 26:127–131PubMed
68.
Zurück zum Zitat Yamanaka Y, Asahina M, Hiraga A, Sakakibara R, Oka H, Hattori T (2007) Over 10 years of isolated autonomic failure preceding dementia and Parkinsonism in 2 patients with Lewy body disease. Mov Disord 22(4):595–597PubMed Yamanaka Y, Asahina M, Hiraga A, Sakakibara R, Oka H, Hattori T (2007) Over 10 years of isolated autonomic failure preceding dementia and Parkinsonism in 2 patients with Lewy body disease. Mov Disord 22(4):595–597PubMed
69.
Zurück zum Zitat Postuma RB, Gagnon JF, Pelletier A, Montplaisir J (2013) Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies. Mov Disord 28:597–604PubMed Postuma RB, Gagnon JF, Pelletier A, Montplaisir J (2013) Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies. Mov Disord 28:597–604PubMed
70.
Zurück zum Zitat Fujishiro H, Iseki E, Nakamura S, Kasanuki K, Chiba Y, Ota K, Murayama N, Sato K (2013) Dementia with Lewy bodies: early diagnostic challenges. Psychogeriatrics 13:128–138PubMed Fujishiro H, Iseki E, Nakamura S, Kasanuki K, Chiba Y, Ota K, Murayama N, Sato K (2013) Dementia with Lewy bodies: early diagnostic challenges. Psychogeriatrics 13:128–138PubMed
71.
Zurück zum Zitat Manabe Y, Inui Y, Toyama H, Kosaka K (2017) 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies. Psychiatry Res Neuroimaging 261:75–79PubMed Manabe Y, Inui Y, Toyama H, Kosaka K (2017) 123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies. Psychiatry Res Neuroimaging 261:75–79PubMed
72.
Zurück zum Zitat Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844PubMed Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 23:837–844PubMed
73.
Zurück zum Zitat Foltynie T, Brayne CE, Robbins TW, Barker RA (2004) The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN Study Brain 127(3):550–560PubMed Foltynie T, Brayne CE, Robbins TW, Barker RA (2004) The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN Study Brain 127(3):550–560PubMed
74.
Zurück zum Zitat Savica R, Boeve BF, Mielke MM (2018) When Do α-synucleinopathies start? An epidemiological timeline: a review. JAMA Neurol 75(4):503–509PubMed Savica R, Boeve BF, Mielke MM (2018) When Do α-synucleinopathies start? An epidemiological timeline: a review. JAMA Neurol 75(4):503–509PubMed
75.
Zurück zum Zitat Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G, Norwegian ParkWest Study Group (2009) Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72:1121–1126PubMed Aarsland D, Bronnick K, Larsen JP, Tysnes OB, Alves G, Norwegian ParkWest Study Group (2009) Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology 72:1121–1126PubMed
76.
Zurück zum Zitat Poletti M, Frosini D, Pagni C, Baldacci F, Nicoletti V, Tognoni G, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U (2012) Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 83:601–606PubMed Poletti M, Frosini D, Pagni C, Baldacci F, Nicoletti V, Tognoni G, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U (2012) Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 83:601–606PubMed
77.
Zurück zum Zitat Yarnall AJ, Breen DP, Duncan GW et al (2014) Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 82:308–316PubMedPubMedCentral Yarnall AJ, Breen DP, Duncan GW et al (2014) Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology 82:308–316PubMedPubMedCentral
78.
Zurück zum Zitat Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM (2017) Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study. Lancet Neurol 16(1):66–75PubMed Schrag A, Siddiqui UF, Anastasiou Z, Weintraub D, Schott JM (2017) Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study. Lancet Neurol 16(1):66–75PubMed
79.
Zurück zum Zitat Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130(7):1787–1798PubMed Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130(7):1787–1798PubMed
80.
Zurück zum Zitat Berg D, Postuma RB, Bloem B et al (2014) Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson's disease. Mov Disord 29(4):454–462PubMedPubMedCentral Berg D, Postuma RB, Bloem B et al (2014) Time to redefine PD? Introductory statement of the MDS task force on the definition of Parkinson's disease. Mov Disord 29(4):454–462PubMedPubMedCentral
81.
Zurück zum Zitat Boeve BF, Dickson DW, Duda JE et al (2016) Arguing against the proposed definition changes of PD. Mov Disord 31(11):1619–1622PubMedPubMedCentral Boeve BF, Dickson DW, Duda JE et al (2016) Arguing against the proposed definition changes of PD. Mov Disord 31(11):1619–1622PubMedPubMedCentral
82.
Zurück zum Zitat Jellinger KA (2018) Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies. J Neural Transm (Vienna) 125(4):615–650 Jellinger KA (2018) Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies. J Neural Transm (Vienna) 125(4):615–650
83.
Zurück zum Zitat Gomperts SN (2016) Lewy body dementias: dementia with lewy bodies and Parkinson disease dementia. Cont. (Minneap Minn) 22:435–463 Gomperts SN (2016) Lewy body dementias: dementia with lewy bodies and Parkinson disease dementia. Cont. (Minneap Minn) 22:435–463
84.
Zurück zum Zitat Aldridge GM, Birnschein A, Denburg NL, Narayanan NS (2018) Parkinson's disease dementia and dementia with lewy bodies have similar neuropsychological profiles. Front Neurol 9:123PubMedPubMedCentral Aldridge GM, Birnschein A, Denburg NL, Narayanan NS (2018) Parkinson's disease dementia and dementia with lewy bodies have similar neuropsychological profiles. Front Neurol 9:123PubMedPubMedCentral
85.
Zurück zum Zitat Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? BMC Med 16(1):34PubMedPubMedCentral Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? BMC Med 16(1):34PubMedPubMedCentral
86.
Zurück zum Zitat Ferman TJ, Smith GE, Kantarci K et al (2013) Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology 81:2032–2038PubMedPubMedCentral Ferman TJ, Smith GE, Kantarci K et al (2013) Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology 81:2032–2038PubMedPubMedCentral
87.
Zurück zum Zitat McKeith IG, Ferman TJ, Thomas AJ et al (2020) Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94(17):743–755PubMedPubMedCentral McKeith IG, Ferman TJ, Thomas AJ et al (2020) Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94(17):743–755PubMedPubMedCentral
88.
Zurück zum Zitat Jicha GA, Schmitt FA, Abner E, Nelson PT, Cooper GE, Smith CD, Markesbery WR (2010) Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging 31:1805–1813PubMed Jicha GA, Schmitt FA, Abner E, Nelson PT, Cooper GE, Smith CD, Markesbery WR (2010) Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging 31:1805–1813PubMed
89.
Zurück zum Zitat McKeith I, Taylor JP, Thomas A, Donaghy P, Kane J (2016) Revisiting DLB diagnosis: a consideration of prodromal DLB and of the diagnostic overlap with alzheimer disease. J Geriatr Psychiatry Neurol 29(5):249–253PubMed McKeith I, Taylor JP, Thomas A, Donaghy P, Kane J (2016) Revisiting DLB diagnosis: a consideration of prodromal DLB and of the diagnostic overlap with alzheimer disease. J Geriatr Psychiatry Neurol 29(5):249–253PubMed
90.
Zurück zum Zitat Berg D, Postuma RB, Adler CH et al (2015) MDS research criteria for prodromal Parkinson's disease. Mov Disord 30(12):1600–1611PubMed Berg D, Postuma RB, Adler CH et al (2015) MDS research criteria for prodromal Parkinson's disease. Mov Disord 30(12):1600–1611PubMed
92.
Zurück zum Zitat van de Beek M, van Steenoven I, van der Zande JJ, Barkhof F, Teunissen CE, van der Flier WM, Lemstra AW (2020) Prodromal dementia with lewy bodies: clinical characterization and predictors of progression. Mov Disord 35(5):859–867PubMedPubMedCentral van de Beek M, van Steenoven I, van der Zande JJ, Barkhof F, Teunissen CE, van der Flier WM, Lemstra AW (2020) Prodromal dementia with lewy bodies: clinical characterization and predictors of progression. Mov Disord 35(5):859–867PubMedPubMedCentral
93.
Zurück zum Zitat Darweesh SKL, Wolters FJ, Postuma RB, Stricker BH, Hofman A, Koudstaal PJ, Ikram MK, Ikram MA (2017) Association between poor cognitive functioning and risk of incident parkinsonism: the rotterdam study. JAMA Neurol 74(12):1431–1438PubMedPubMedCentral Darweesh SKL, Wolters FJ, Postuma RB, Stricker BH, Hofman A, Koudstaal PJ, Ikram MK, Ikram MA (2017) Association between poor cognitive functioning and risk of incident parkinsonism: the rotterdam study. JAMA Neurol 74(12):1431–1438PubMedPubMedCentral
94.
Zurück zum Zitat Donaghy PC, McKeith IG (2014) The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther 6(4):46PubMedPubMedCentral Donaghy PC, McKeith IG (2014) The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther 6(4):46PubMedPubMedCentral
95.
Zurück zum Zitat Wenning GK, Geser F, Krismer F et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12(3):264–274PubMedPubMedCentral Wenning GK, Geser F, Krismer F et al (2013) The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12(3):264–274PubMedPubMedCentral
96.
Zurück zum Zitat Batla A, Stamelou M, Mensikova K, Kaiserova M, Tuckova L, Kanovsky P, Quinn N, Bhatia KP (2013) Markedly asymmetric presentation in multiple system atrophy. Parkinsonism Relat Disord 19(10):901–905PubMed Batla A, Stamelou M, Mensikova K, Kaiserova M, Tuckova L, Kanovsky P, Quinn N, Bhatia KP (2013) Markedly asymmetric presentation in multiple system atrophy. Parkinsonism Relat Disord 19(10):901–905PubMed
97.
Zurück zum Zitat Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A (2019) Dyskinesia in multiple system atrophy and progressive supranuclear palsy. J Neural Transm (Vienna) 126(7):925–932 Jost WH, Lingor P, Tönges L, Schwarz J, Buhmann C, Kassubek J, Schrag A (2019) Dyskinesia in multiple system atrophy and progressive supranuclear palsy. J Neural Transm (Vienna) 126(7):925–932
98.
Zurück zum Zitat Petrovic IN, Ling H, Asi Y, Ahmed Z, Kukkle PL, Hazrati L-N, Lang AE, Revesz T, Holton JL, Lees AL (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27(9):1186–1190PubMed Petrovic IN, Ling H, Asi Y, Ahmed Z, Kukkle PL, Hazrati L-N, Lang AE, Revesz T, Holton JL, Lees AL (2012) Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 27(9):1186–1190PubMed
99.
Zurück zum Zitat Batla A, De Pablo-Fernandez E, Erro R et al (2018) Young-onset multiple system atrophy: clinical and pathological features. Mov Disord 33:1099–1107PubMed Batla A, De Pablo-Fernandez E, Erro R et al (2018) Young-onset multiple system atrophy: clinical and pathological features. Mov Disord 33:1099–1107PubMed
100.
Zurück zum Zitat Watanabe H, Riku Y, Hara K, Kawabata K, Nakamura T, Ito M, Hirayama M, Yoshida M, Katsuno M, Sobue G (2018) Clinical and imaging features of multiple system atrophy: challenges for an early and clinically definitive diagnosis. J Mov Disord 11(3):107–120PubMedPubMedCentral Watanabe H, Riku Y, Hara K, Kawabata K, Nakamura T, Ito M, Hirayama M, Yoshida M, Katsuno M, Sobue G (2018) Clinical and imaging features of multiple system atrophy: challenges for an early and clinically definitive diagnosis. J Mov Disord 11(3):107–120PubMedPubMedCentral
101.
Zurück zum Zitat Stankovic I, Krismer F, Jesic A et al (2014) Cognitive impairment in multiple system atrophy: a position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group. Mov Disord 29(7):857–867PubMedPubMedCentral Stankovic I, Krismer F, Jesic A et al (2014) Cognitive impairment in multiple system atrophy: a position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group. Mov Disord 29(7):857–867PubMedPubMedCentral
102.
Zurück zum Zitat Zhang L, Cao B, Ou R, Wei Q-Q, Zhao B, Yang J, Wu Y, Shang H (2017) Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes. Parkinsonism Relat Disord 35:63–68PubMed Zhang L, Cao B, Ou R, Wei Q-Q, Zhao B, Yang J, Wu Y, Shang H (2017) Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes. Parkinsonism Relat Disord 35:63–68PubMed
103.
Zurück zum Zitat Cykowski MD, Coon EA, Powell SZ, Jenkins SM, Benarroch EE, Low PA, Schmeichel AM, Parisi JE (2015) Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 138:2293–2309PubMedPubMedCentral Cykowski MD, Coon EA, Powell SZ, Jenkins SM, Benarroch EE, Low PA, Schmeichel AM, Parisi JE (2015) Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain 138:2293–2309PubMedPubMedCentral
104.
Zurück zum Zitat Auzou N, Dujardin K, Biundo R, Foubert-Samier A, Barth C, Duval F, Tison F, Defebvre L, Antonini A, Meissner WG (2015) Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia. Parkinsonism Relat Disord 21(10):1273–1277PubMed Auzou N, Dujardin K, Biundo R, Foubert-Samier A, Barth C, Duval F, Tison F, Defebvre L, Antonini A, Meissner WG (2015) Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia. Parkinsonism Relat Disord 21(10):1273–1277PubMed
105.
Zurück zum Zitat Pillon B, Gouider-Khouja N, Vidailhet DB, Malapani C, Dubois B, Agid Y, (1995) Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson’s disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 58:174–179PubMedPubMedCentral Pillon B, Gouider-Khouja N, Vidailhet DB, Malapani C, Dubois B, Agid Y, (1995) Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson’s disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 58:174–179PubMedPubMedCentral
106.
Zurück zum Zitat Soliveri P, Monza D, Paridi D, Carella F, Genitrini S, Testa D, Girotti F (2000) Neuropsychological follow up in patients with Parkinson’s disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 69:313–318PubMedPubMedCentral Soliveri P, Monza D, Paridi D, Carella F, Genitrini S, Testa D, Girotti F (2000) Neuropsychological follow up in patients with Parkinson’s disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 69:313–318PubMedPubMedCentral
107.
Zurück zum Zitat O’Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, Revesz T, Lees AJ (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131:1362–1372PubMed O’Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, Revesz T, Lees AJ (2008) Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 131:1362–1372PubMed
108.
Zurück zum Zitat Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K (2009) Assessment of dementia in patients with multiple system atrophy. Eur J Neurol 16:589–594PubMed Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K (2009) Assessment of dementia in patients with multiple system atrophy. Eur J Neurol 16:589–594PubMed
109.
Zurück zum Zitat Koga S, Parks A, Uitti RJ, van Gerpen JA, Cheshire WP, Wszolek ZK, Dickson DW (2017) Profile of cognitive impairment and underlying pathology in multiple system atrophy. Mov Disord 32(3):405–413PubMed Koga S, Parks A, Uitti RJ, van Gerpen JA, Cheshire WP, Wszolek ZK, Dickson DW (2017) Profile of cognitive impairment and underlying pathology in multiple system atrophy. Mov Disord 32(3):405–413PubMed
110.
Zurück zum Zitat Eschlböck S, Delazer M, Krismer F et al (2020) Cognition in multiple system atrophy: a single-center cohort study. Ann Clin Transl Neurol 7(2):219–228PubMedPubMedCentral Eschlböck S, Delazer M, Krismer F et al (2020) Cognition in multiple system atrophy: a single-center cohort study. Ann Clin Transl Neurol 7(2):219–228PubMedPubMedCentral
111.
Zurück zum Zitat Kim HJ, Jeon BS, Kim YE, Kim JY, Kim YK, Sohn CH, Yun JY, Jeon S, Lee JM, Lee JY (2013) Clinical and imaging characteristics of dementia in multiple system atrophy. Parkinsonism Relat Disord 19:617–621PubMed Kim HJ, Jeon BS, Kim YE, Kim JY, Kim YK, Sohn CH, Yun JY, Jeon S, Lee JM, Lee JY (2013) Clinical and imaging characteristics of dementia in multiple system atrophy. Parkinsonism Relat Disord 19:617–621PubMed
112.
Zurück zum Zitat Siri C, Duerr S, Canesi M et al (2013) A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type. J Neural Transm (Vienna) 120(4):613–618 Siri C, Duerr S, Canesi M et al (2013) A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type. J Neural Transm (Vienna) 120(4):613–618
113.
Zurück zum Zitat Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R (2016) Montreal cognitive assessment (MOCA) and mini-mental state examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. J Neural Transm (Vienna) 123:1435–1442 Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R (2016) Montreal cognitive assessment (MOCA) and mini-mental state examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy. J Neural Transm (Vienna) 123:1435–1442
114.
Zurück zum Zitat Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F et al (2008) Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P. Neurology 70(2):1390–1396PubMed Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F et al (2008) Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P. Neurology 70(2):1390–1396PubMed
115.
Zurück zum Zitat Chang CC, Chang YY, Chang WN, Lee YC, Wang YL, Lui CC, Huang CW, Liu WL (2009) Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration. Eur J Neurol 16(10):1144–1150PubMed Chang CC, Chang YY, Chang WN, Lee YC, Wang YL, Lui CC, Huang CW, Liu WL (2009) Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration. Eur J Neurol 16(10):1144–1150PubMed
116.
Zurück zum Zitat Fiorenzato E, Weis L, Seppi K et al (2017) Brain structural profile of multiple system atrophy patients with cognitive impairment. J Neural Transm (Vienna) 124(3):293–302 Fiorenzato E, Weis L, Seppi K et al (2017) Brain structural profile of multiple system atrophy patients with cognitive impairment. J Neural Transm (Vienna) 124(3):293–302
117.
Zurück zum Zitat Barcelos LB, Saad F, Giacominelli C, Saba RA, de Carvalho Aguiar PM, Silva SMA, Borges V, Bertolucci PHF, Ferraz HB (2018) Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy. Clin Neurol Neurosurg 164:121–126PubMed Barcelos LB, Saad F, Giacominelli C, Saba RA, de Carvalho Aguiar PM, Silva SMA, Borges V, Bertolucci PHF, Ferraz HB (2018) Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy. Clin Neurol Neurosurg 164:121–126PubMed
118.
Zurück zum Zitat Aoki N, Boyer PJ, Lund C et al (2015) Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein. Acta Neuropathol 130:93–105PubMedPubMedCentral Aoki N, Boyer PJ, Lund C et al (2015) Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein. Acta Neuropathol 130:93–105PubMedPubMedCentral
119.
Zurück zum Zitat Brown RG, Lacomblez L, Landwehrmeyer BG et al (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133:2382–2393PubMed Brown RG, Lacomblez L, Landwehrmeyer BG et al (2010) Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain 133:2382–2393PubMed
120.
Zurück zum Zitat Udow SJ, Robertson AD, MacIntosh BJ, Espay AJ, Rowe JB, Lang AE, Masellis M (2016) 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? J Neurol Neurosurg Psychiatry 87(12):1311–1321PubMed Udow SJ, Robertson AD, MacIntosh BJ, Espay AJ, Rowe JB, Lang AE, Masellis M (2016) 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies? J Neurol Neurosurg Psychiatry 87(12):1311–1321PubMed
122.
Zurück zum Zitat Sambati L, Calandra-Buonaura G, Poda R, Guaraldi P, Cortelli P (2014) Orthostatic hypotension and cognitive impairment: a dangerous association? Neurol Sci 35(6):951–957PubMed Sambati L, Calandra-Buonaura G, Poda R, Guaraldi P, Cortelli P (2014) Orthostatic hypotension and cognitive impairment: a dangerous association? Neurol Sci 35(6):951–957PubMed
123.
Zurück zum Zitat Sonnesyn H, Nilsen DW, Rongve A, Nore S, Ballard C, Tysnes OB, Aarsland D (2009) High prevalence of orthostatic hypotension in mild dementia. Dement Geriatr Cogn Disord 28:307–313PubMed Sonnesyn H, Nilsen DW, Rongve A, Nore S, Ballard C, Tysnes OB, Aarsland D (2009) High prevalence of orthostatic hypotension in mild dementia. Dement Geriatr Cogn Disord 28:307–313PubMed
124.
Zurück zum Zitat Wolters FJ, Mattace-Raso FU, Koudstaal PJ, Hofman A, Ikram MA, Heart Brain Connection Collaborative Research Group (2016) Orthostatic Hypotension and the Long-Term Risk of Dementia: A Population-Based Study. PLoS Med 13(10):e1002143PubMedPubMedCentral Wolters FJ, Mattace-Raso FU, Koudstaal PJ, Hofman A, Ikram MA, Heart Brain Connection Collaborative Research Group (2016) Orthostatic Hypotension and the Long-Term Risk of Dementia: A Population-Based Study. PLoS Med 13(10):e1002143PubMedPubMedCentral
125.
Zurück zum Zitat Kim JS, Oh YS, Lee KS, Kim YI, Yang DW, Goldstein DS (2012) Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79(13):1323–1331PubMedPubMedCentral Kim JS, Oh YS, Lee KS, Kim YI, Yang DW, Goldstein DS (2012) Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease. Neurology 79(13):1323–1331PubMedPubMedCentral
126.
Zurück zum Zitat Allcock LM, Kenny RA, Mosimann UP, Tordoff S, Wesnes KA, Hildreth AJ, Burn DJ (2006) Orthostatic hypotension in Parkinson's disease: association with cognitive decline? Int J Geriatr Psychiatry 21:778–783PubMed Allcock LM, Kenny RA, Mosimann UP, Tordoff S, Wesnes KA, Hildreth AJ, Burn DJ (2006) Orthostatic hypotension in Parkinson's disease: association with cognitive decline? Int J Geriatr Psychiatry 21:778–783PubMed
127.
Zurück zum Zitat Allcock LM, Kenny RA, Burn DJ (2006) Clinical phenotype of subjects with Parkinson’s disease and orthostatic hypotension: autonomic symptom and demographic comparison. Mov Disord 21:1851–1855PubMed Allcock LM, Kenny RA, Burn DJ (2006) Clinical phenotype of subjects with Parkinson’s disease and orthostatic hypotension: autonomic symptom and demographic comparison. Mov Disord 21:1851–1855PubMed
128.
Zurück zum Zitat Idiaquez J, Benarroch EE, Rosales H, Milla P, Rios L (2007) Autonomic and cognitive dysfunction in Parkinson's disease. Clin Auton Res 17:93–98PubMed Idiaquez J, Benarroch EE, Rosales H, Milla P, Rios L (2007) Autonomic and cognitive dysfunction in Parkinson's disease. Clin Auton Res 17:93–98PubMed
129.
Zurück zum Zitat Peralta C, Stampfer-Kountchev M, Karner E, Kollensperger M, Geser F, Wolf E, Seppi K, Benke T, Poewe W, Wenning GK (2007) Orthostatic hypotension and attention in Parkinson’s disease with and without dementia. J Neural Transm 114:585–588PubMed Peralta C, Stampfer-Kountchev M, Karner E, Kollensperger M, Geser F, Wolf E, Seppi K, Benke T, Poewe W, Wenning GK (2007) Orthostatic hypotension and attention in Parkinson’s disease with and without dementia. J Neural Transm 114:585–588PubMed
130.
Zurück zum Zitat Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M (2005) Three-dimensional stereotactic surface projection study of orthostatic hypotension and brain perfusion image in Parkinson’s disease. Acta Neurol Scand 112(1):36–41PubMed Matsui H, Udaka F, Miyoshi T, Hara N, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M (2005) Three-dimensional stereotactic surface projection study of orthostatic hypotension and brain perfusion image in Parkinson’s disease. Acta Neurol Scand 112(1):36–41PubMed
131.
Zurück zum Zitat Pilleri M, Facchini S, Gasparoli E, Biundo R, Bernardi L, Marchetti M, Formento P, Antonini A (2013) Cognitive and MRI correlates of orthostatic hypotension in Parkinson’s disease. J Neurol 260:253–259PubMed Pilleri M, Facchini S, Gasparoli E, Biundo R, Bernardi L, Marchetti M, Formento P, Antonini A (2013) Cognitive and MRI correlates of orthostatic hypotension in Parkinson’s disease. J Neurol 260:253–259PubMed
132.
Zurück zum Zitat Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A (2017) Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology 88(1):17–24PubMedPubMedCentral Centi J, Freeman R, Gibbons CH, Neargarder S, Canova AO, Cronin-Golomb A (2017) Effects of orthostatic hypotension on cognition in Parkinson disease. Neurology 88(1):17–24PubMedPubMedCentral
133.
Zurück zum Zitat McDonald C, Newton JL, Burn DJ (2016) Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association? Mov Disord 31(7):937–946PubMed McDonald C, Newton JL, Burn DJ (2016) Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association? Mov Disord 31(7):937–946PubMed
Metadaten
Titel
Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
verfasst von
Giovanni Palermo
Eleonora Del Prete
Ubaldo Bonuccelli
Roberto Ceravolo
Publikationsdatum
27.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 12/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-020-09985-z

Weitere Artikel der Ausgabe 12/2020

Journal of Neurology 12/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.